Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for BAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -5.00M
March 31, 2026 -8.00M
December 31, 2025 -5.00M
September 30, 2025 -9.00M
June 30, 2025 -6.00M
March 31, 2025 -10.00M
December 31, 2024 -8.00M
September 30, 2024 -11.00M
June 30, 2024 -12.00M
March 31, 2024 -40.00M
December 31, 2023 -9.00M
September 30, 2023 -32.00M
June 30, 2023 -18.00M
March 31, 2023 -36.00M
December 31, 2022 -13.00M
September 30, 2022 6.00M
June 30, 2022 -22.00M
March 31, 2022 -66.00M
December 31, 2021 -52.00M
September 30, 2021 -7.00M
June 30, 2021 267.00M
March 31, 2021 205.00M
December 31, 2020 478.00M
September 30, 2020 -29.00M
June 30, 2020 -85.00M
Date Value
March 31, 2020 -66.00M
December 31, 2019 219.00M
September 30, 2019 237.00M
June 30, 2019 34.00M
March 31, 2019 424.00M
December 31, 2018 1.398B
September 30, 2018 185.00M
June 30, 2018 171.00M
March 31, 2018 440.00M
December 31, 2017 240.00M
September 30, 2017 82.00M
June 30, 2017 -45.00M
March 31, 2017 -60.00M
December 31, 2016 247.00M
September 30, 2016 45.00M
June 30, 2016 99.00M
March 31, 2016 -99.00M
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 48.00M
March 31, 2015 -48.00M
December 31, 2014 50.00M
September 30, 2014 50.00M
June 30, 2014 200.00M
March 31, 2014 250.00M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
DexCom, Inc. 603.60M
Becton, Dickinson & Co. 0.00
Boston Scientific Corp. 1.995B
West Pharmaceutical Services, Inc. 147.90M
Abbott Laboratories 1.042B